Anyone know what's happening with API? They have been quiet for quite some time now. Other than their Bundamba distribution centre reopening in QLD this August there seems to be nothing in the horizon in terms of info. What is perhaps most disconcerting as a shareholder is the issue of bullying over direct supplier contracts. In contrast to API's stock price, Sigma Pharmaceuticals seems to be doing way better. Can we assume that they have been successful in their bid for market share?
so what's happening with api?
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
